These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 11090072)
1. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072 [TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas. Ströbel P; Helmreich M; Menioudakis G; Lewin SR; Rüdiger T; Bauer A; Hoffacker V; Gold R; Nix W; Schalke B; Elert O; Semik M; Müller-Hermelink HK; Marx A Blood; 2002 Jul; 100(1):159-66. PubMed ID: 12070022 [TBL] [Abstract][Full Text] [Related]
3. Paraneoplastic diseases associated with thymoma. Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820 [TBL] [Abstract][Full Text] [Related]
4. Pathomechanisms of paraneoplastic myasthenia gravis. Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152 [TBL] [Abstract][Full Text] [Related]
5. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy. Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743 [TBL] [Abstract][Full Text] [Related]
6. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312 [TBL] [Abstract][Full Text] [Related]
7. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma. Ichikawa Y; Shimizu H; Yoshida M; Arimori S Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261 [TBL] [Abstract][Full Text] [Related]
9. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells. Fujii Y; Hayakawa M; Inada K; Nakahara K Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007 [TBL] [Abstract][Full Text] [Related]
10. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas. Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765 [TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic autoimmunity in thymus tumors. Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914 [TBL] [Abstract][Full Text] [Related]
12. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674 [TBL] [Abstract][Full Text] [Related]
13. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4 Wang T; Wang B; Fan X; Cai Y; Li L; Fu S Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105 [TBL] [Abstract][Full Text] [Related]
14. A CTLA4high genotype is associated with myasthenia gravis in thymoma patients. Chuang WY; Ströbel P; Gold R; Nix W; Schalke B; Kiefer R; Opitz A; Klinker E; Müller-Hermelink HK; Marx A Ann Neurol; 2005 Oct; 58(4):644-8. PubMed ID: 16178018 [TBL] [Abstract][Full Text] [Related]
15. T-cell development in human thymoma. Inoue M; Fujii Y; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H Pathol Res Pract; 1999; 195(8):541-7. PubMed ID: 10483584 [TBL] [Abstract][Full Text] [Related]
16. Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells. Inoue M; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Shirakura R; Matsuda H Clin Exp Immunol; 1999 Jul; 117(1):1-7. PubMed ID: 10403908 [TBL] [Abstract][Full Text] [Related]
17. T lymphocyte activation in myasthenic thymoma. Takahashi K; Saito S; Monden Y Autoimmunity; 1998; 28(3):173-82. PubMed ID: 9867130 [TBL] [Abstract][Full Text] [Related]
18. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis. Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972 [TBL] [Abstract][Full Text] [Related]
19. The role of T-cells in the initiation of autoantibody responses in thymoma patients. Vincent A; Willcox N Pathol Res Pract; 1999; 195(8):535-40. PubMed ID: 10483583 [TBL] [Abstract][Full Text] [Related]
20. [Changes in clinical and immunological status after post-thymectomized irradiation for invasive thymoma with myasthenia gravis]. Ishida S Rinsho Shinkeigaku; 1996 May; 36(5):629-32. PubMed ID: 8905980 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]